CCR7 and Schnyder corneal dystrophy: Treatment with the CB2 selective agonist, JWH-133, induced a reduction of both M1 markers, CD86 and CCR7, in a statistically manner in SCD treated macrophages compared to untreated (NT) ones (p = 0,0156 and p = 0,0436, respectively) (Fig. 4A, B).